Changing epidemiology of clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England

Clinical Infectious Diseases

Volumn 55, Issue 8, 2012, Pages 1056-1063

  Wilcox, M H ^a   Shetty, N ^b   Fawley, W N ^a   Shemko, M ^b   Coen, P ^b   Birtles, A ^c   Cairns, M ^d   Curran, M D ^e   Dodgson, K J ^c   Green, S M ^f   Hardy, K J ^g   Hawkey, P M ^g   Magee, J G ^h   Sails, A D ^h   Wren, M W D ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^g UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^h ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEPHALOSPORIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE;

ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM DIFFICILE INFECTION; PLUS CLAVULANIC ACID; DISEASE SURVEILLANCE; EPIDEMIC; MORTALITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; ENGLAND; FECES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PREVALENCE; PUBLIC HEALTH SURVEILLANCE; RIBOTYPING;

EID: 84866675037     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis614     Document Type: Review

References (26)

1. Freeman J, Bauer MP, Baines SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010; 23:529-49.
2. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficileassociated disease in North America and Europe. Clin Microbiol Infect 2006; 12(suppl 6):2-18.
3. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366:1079-84.
4. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007; 142:624-31.
5. Health Protection Agency and Department of Health. Clostridium difficile infection: how to deal with the problem. Available at: http://www.hpa.org.uk/ web/HPAwebFile/HPAweb-C/1232006607827. Accessed 4 January 2012.
6. Department of Health (England). Changes to the mandatory healthcare associated infection surveillance system for Clostridium difficile associated diarrhoea from April 2007. Available at: http://www.dh.gov. uk/prod-consum-dh/ groups/dh-digitalassets/documents/digitalasset/dh-073766pdf Accessed 4 January 2012.
7. Department of Health (England). National target to reduce Clostridium difficile infections. Available at: http://www.dh.gov.uk/prod-consum-dh/groups/ dh-digitalassets/@dh/@en/documents/digitalasset/dh-082653pdf Accessed 4 January 2012.
8. Health Protection Agency. Clostridium difficile Ribotyping Network (CDRN) Service. Available at: http://www.hpa.org.uk/Products Services/ InfectiousDiseases/LaboratoriesAndReferenceFacilities/Clostri diumDifficileRibotypingNetworkService/. Accessed 4 January 2012.
9. Stubbs SL, Brazier JS, O'Neill GL, Duerden BI. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 1999; 37:461-3.
10. Griffiths D, Fawley W, Kachrimanidou M, et al. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol 2010; 48:770-8.
11. Health Protection Agency. Results of the mandatory Clostridium difficile reporting scheme. Available at: http://www.hpa.org.uk/web/ HPAweb&HPAwebStandard/HPAweb-C/1195733750761. Accessed 29 January 2012.
12. Office for National Statistics. Deaths involving Clostridium difficile: England and Wales, 2006 to 2010. Available at: http://www.ons.gov. uk/ons/rel/subnational-health2/deaths-involving-clostridium-difficile/ 2006-to-2010/statistical-bulletin.html Accessed 4 January 2012.
13. Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol 2009; 30:57-66.
14. Smith A. Outbreak of Clostridium difficile infection in an English hospital linked to hypertoxin-producing strains in Canada and the US. Euro Surveill 2005; 10:E050630-2.
15. Goorhuis A, Debast SB, van Leengoed LA, et al. Clostridium difficile PCR ribotype 078: an emerging strain in humans and in pigs? J Clin Microbiol 2008; 46:1157-8.
16. Bauer MP, Notermans DW, van Benthem BH, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2010; 377:63-73.
17. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173:1037-42.
18. Miller M, Gravel D, Mulvey M, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2009; 50:194-201.
19. Lamontagne F, Labbe AC, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 2007; 245:267-72.
20. Osman KA, Ahmed MH, Hamad MA, Mathur D. Emergency colectomy for fulminant Clostridium difficile colitis: striking the right balance. Scand J Gastroenterol 2011; 46:1222-7.
21. van der Kooi TI, Koningstein M, Lindemans A, et al. Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027. J Med Microbiol 2008; 57:709-16.
22. Davey P, Brown E, Fenelon L, et al. Interventions to improve antibiotic prescribing practices for hospital in-patients. Cochrane Database Syst Rev 2005; 4:CD003543.
23. Settle CD, Wilcox MH, Fawley WN, Corrado OJ, Hawkey PM. Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam. Aliment Pharmacol Ther 1998; 12:1217-23.
24. Thomas C, Stevenson M, Riley TV. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 2003; 51:1339-50.
25. Brazier JS, Raybould R, Patel B, et al. Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08. Euro Surveill 2008; 13: pii:19000: 1-5.
26. Fawley WN, Wilcox MH. An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR ribotype. J Clin Microbiol 2011; 49: 4333-7.